Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
Figure 5
(a) In vitro dissolution profile for liquisolid compacts with 40% [w/w] drug concentration. (b) In vitro dissolution profile for liquisolid compacts with 20% [w/w] drug concentration.